🌿 Environment Aug 13, 2026 · Kristin Jensen

PTC takes a chance on Sangamo’s Fabry disease gene therapy

BioPharma Dive
BioPharma industry news
View Channel →
PTC takes a chance on Sangamo’s Fabry disease gene therapy
Source ↗ 👁 2 💬 0
Wall Street analysts view the deal as a risky, high-reward bet on a treatment that’s nearing a possible regulatory approval and could be superior to existing medications.

Comments (0)

Sign in to join the discussion

More Like This

London’s low emission zone is working – so why are cities around the world so cautious about clean air?
Environment | The Guardian · 2d ago
Onshore windfarm applications hit 10-year high in England
Environment | The Guardian · 2d ago
Drill, Burnham, drill? The oil basin that is a totem for Trump - and a headache for Britain’s new PM
Environment | The Guardian · 2d ago
Heathrow expansion ‘is threat to England’s largest surviving medieval barn’
Environment | The Guardian · 2d ago
‘Devastating’: Western Australia fears a black swan moment as bird flu threatens flagship species
Environment | The Guardian · 2d ago
U.S. Cuts Colorado River Water for Arizona, California and Nevada
NYT > Climate and Environment · 2d ago